ICOSAPENT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Icosapent, and when can generic versions of Icosapent launch?
Icosapent is a drug marketed by Apotex, Ascent Pharms Inc, Dr Reddys, Hikma, Humanwell Puracap, Onesource Specialty, Pharmobedient, Qilu, Teva Pharms Usa, Xiamen Lp Pharm Co, and Zydus Lifesciences. and is included in eleven NDAs.
The generic ingredient in ICOSAPENT is icosapent ethyl. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Icosapent
A generic version of ICOSAPENT was approved as icosapent ethyl by HIKMA on May 21st, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ICOSAPENT?
- What are the global sales for ICOSAPENT?
- What is Average Wholesale Price for ICOSAPENT?
Summary for ICOSAPENT
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for ICOSAPENT |
| DailyMed Link: | ICOSAPENT at DailyMed |
US Patents and Regulatory Information for ICOSAPENT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209437-001 | Jun 30, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Lifesciences | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 217656-001 | Apr 20, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209457-002 | Mar 8, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209499-001 | Aug 7, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 218994-001 | Dec 20, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
